Anand-Apte B, Zetter B R, Viswanathan A, Qiu R G, Chen J, Ruggieri R, Symons M
Department of Surgery, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Biol Chem. 1997 Dec 5;272(49):30688-92. doi: 10.1074/jbc.272.49.30688.
Directed cell migration is essential for a variety of important biological processes ranging from development and angiogenesis to metastasis. Ras plays a pivotal role in the signaling cascade that governs chemotaxis of fibroblasts toward platelet-derived growth factor-BB (PDGF-BB). Ras activates multiple downstream pathways, which include the extracellular signal-regulated kinase (ERK), Rac, and Ral signaling cascades. We therefore investigated the role of the Rac and ERK pathways in cell migration. We showed that migration of fibroblasts toward PDGF-BB is inhibited by expression of dominant negative Asn-17 Rac1. Blocking of the ERK pathway by either expression of dominant negative Ala-218/Ala-222-mitogen-activated protein kinase kinase (A218/A222-MEK1) or by a MEK-specific inhibitor did not inhibit migration toward PDGF-BB. In contrast, migration toward soluble fibronectin was suppressed by inhibition of the ERK pathway but not by Asn-17 Rac1 expression. These results indicate that directed cell migration mediated by different receptor classes in response to different ligands differentially utilizes the Rac and ERK pathways and suggest that Rac might play a critical role in pathological processes such as angiogenesis and metastasis.
定向细胞迁移对于从发育、血管生成到转移等各种重要的生物学过程至关重要。Ras在控制成纤维细胞向血小板衍生生长因子-BB(PDGF-BB)趋化的信号级联反应中起关键作用。Ras激活多个下游途径,包括细胞外信号调节激酶(ERK)、Rac和Ral信号级联反应。因此,我们研究了Rac和ERK途径在细胞迁移中的作用。我们发现,显性负性Asn-17 Rac1的表达抑制了成纤维细胞向PDGF-BB的迁移。通过显性负性Ala-218/Ala-222-丝裂原活化蛋白激酶激酶(A218/A222-MEK1)的表达或MEK特异性抑制剂阻断ERK途径,均未抑制向PDGF-BB的迁移。相反,抑制ERK途径可抑制向可溶性纤连蛋白的迁移,但Asn-17 Rac1的表达则无此作用。这些结果表明,不同受体类别介导的、对不同配体作出反应的定向细胞迁移以不同方式利用Rac和ERK途径,并提示Rac可能在血管生成和转移等病理过程中起关键作用。